Channels - Bullous Pemphigoid Possibly Induced by Deucravacitinib in a Patient with Psoriasis :: FRELIP Discovery

Similar Items: Bullous Pemphigoid Possibly Induced by Deucravacitinib in a Patient with Psoriasis

Quick Look
Successful Treatment of IL‐23 Inhibitor–Refractory Nail Psoriasis With Deucravacitinib: A Case Report
Quick Look
Autoimmunity to Collagen XVII (BP180-Ag2) in Pemphigoid Associated With Parkinson’s Disease
Quick Look
Pingueculitis in psoriasis patient on secukinumab – An unreported adverse event
Quick Look
Immunosenescence in Older Patients with Psoriasis: Mechanistic Insights and Opportunities for Biologic Therapy
Quick Look
A Rapidly Evolving Vesiculobullous Eruption in a Toddler: A Case of Linear IgA Bullous Dermatosis
Quick Look
Beyond Psoriasis Area and Severity Index and Body Surface Area: An Italian Delphi Consensus on the Definition of Moderate Psoriasis
Quick Look
Paraneoplastic Papuloerythroderma of Ofuji Masquerading as Worsening Psoriasis
Quick Look
Application of Trichoscopy and Novel Non-Invasive Imaging Techniques in the Diagnosis and Management of Patients with Scalp Psoriasis
Quick Look
Effects of Tirzepatide on Metabolic Parameters in Patients with Psoriasis and Obesity: 24-Week Real-World Study
Quick Look
Cost–Effectiveness Analysis of Bimekizumab against Interleukin-23 Inhibitors in Patients with Plaque Psoriasis in Japan
Quick Look
Evaluating the Role of Disease Duration in Systemic Therapy Response Among Patients with Moderate-to-Severe Psoriasis
Quick Look
Prevalence of Genital Psoriasis and Its Impact on Patients’ Sexual Life in Routine Care: Epidemiologic Survey in Germany
Quick Look
Real‐World, Prospective, Multicenter Outcomes to Brodalumab Treatment in Patients With Moderate‐to‐Severe Psoriasis in Greece (The RESOLVE Study)
Quick Look
Long-Term Real-World Effectiveness and Drug Survival of Guselkumab in Patients with Psoriasis: A 5-Year Retrospective Study
Quick Look
Development of Predictive Models for NB-UVB Treatment Efficacy and Safety in Psoriasis
Quick Look
Bidirectional Associations Between Substance Abuse and Psoriasis: A Prospective Cohort Study
Quick Look
New Tuberculosis Infection and Reactivation of Tuberculosis in Patients with Psoriasis or Psoriatic Arthritis Receiving IL-23 Inhibitors: A Systematic Literature Review
Quick Look
The Psoriatic Disease Assessment Index (PSODAI) Score to Evaluate Systemic Involvement of Psoriasis
Quick Look
Predictors of Successful Secukinumab Dose Tapering in Moderate-to-Severe Psoriasis: A Retrospective Study
Quick Look
Persistence and Long-Term Disease Control of Interleukin-17 Inhibitors and Interleukin-23 Inhibitors in Patients with Psoriasis: A Nationwide Cohort Study in Japan
Quick Look
Patient Characteristics, Disease Profile and Treatment Patterns in Mild and Moderate Psoriasis Patients: Results From Real‐World Clinical Practices in Five European Countries (PROSPECT Study)
Quick Look
Core Differentially Expressed Genes in Psoriasis Lesions: An Integrated Analysis of Four GEO Datasets
Quick Look
Global Trends and Future Predictions of Psoriasis Burden: Insights from the GBD 2021 Study
Quick Look
Impact of Biologic Treatment Duration on Drug-Free Remission in Moderate-to-Severe Psoriasis: A Retrospective Cohort Study